[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.180.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 338
Citations 0
Comment & Response
July 2016

Prenatal Antidepressant Use and Risk of Autism Spectrum Disorders in Children

Author Affiliations
  • 1Department of Pharmacology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey
  • 2Terafar-Izmir Katip Celebi University Teratology Information, Training and Research Center, Izmir, Turkey
JAMA Pediatr. 2016;170(7):712. doi:10.1001/jamapediatrics.2016.0727

To the Editor The register-based cohort study by Boukhris et al1 investigating the association between prenatal antidepressant use and risk of autism spectrum disorders (ASD) in the offspring was interesting. The authors reported a significant increase in risk of ASD in children whose mothers were exposed to antidepressants and selective serotonin reuptake inhibitors (SSRIs) in the second and/or third trimesters of their pregnancy. However, we believe that the study suffers from incomplete reporting and discussion of the results, which may lead to significant misinterpretations.

First Page Preview View Large
First page PDF preview
First page PDF preview
×